Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2014-02, Vol.70 (2), p.e37-e38
Main Authors: Routt, Ethan T., BA, Levitt, Jacob O., MD
Format: Article
Language:English
Subjects:
Administration, Cutaneous
Adult
Brimonidine Tartrate
Dermatology
Dose-Response Relationship, Drug
Drug Administration Schedule
Erythema - chemically induced
Erythema - physiopathology
Female
Follow-Up Studies
Gels - therapeutic use
Humans
Pain - chemically induced
Quinoxalines - adverse effects
Quinoxalines - therapeutic use
Recurrence
Risk Assessment
Rosacea - diagnosis
Rosacea - drug therapy
Sampling Studies
Severity of Illness Index
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603
cites cdi_FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603
container_end_page e38
container_issue 2
container_start_page e37
container_title Journal of the American Academy of Dermatology
container_volume 70
creator Routt, Ethan T., BA
Levitt, Jacob O., MD
description
doi_str_mv 10.1016/j.jaad.2013.10.054
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490900136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962213011778</els_id><sourcerecordid>1490900136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603</originalsourceid><addsrcrecordid>eNp9kd2L1TAQxYMo7nX1H_BB8uhL66RpmxREkMUvWBD8wMcwTadraptck3bl_vem3NUHH3waZjjnwPwOY08FlAJE-2IqJ8ShrEDIfCihqe-xg4BOFa3S6j47gOig6NqqumCPUpoAoKulesguqrqWulPtgX37RH3Y_MApntbvtCDHvPRb9M7f8EQ-4eqC52MMC0fu6Rdfw9FZnHkf3RK8G5wnvmJcI67Eb2jmUEr5mD0YcU705G5esq9v33y5el9cf3z34er1dWHrplkLPVZSktSDHBC0aqUla0WDSFKpxkprtaS6R5A1VnqoUIthFCjaVmrAFuQle37OPcbwc6O0msUlS_OMnsKWjKg76CATarO0OkttDClFGs0xf4DxZASYHaiZzA7U7ED3WwaaTc_u8rd-oeGv5Q_BLHh5FlD-8tZRNMk68pYGF8muZgju__mv_rHb2fmd7w86UZpCbiLzM8KkyoD5vFe6NyokCKGUlr8BFqSbJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490900136</pqid></control><display><type>article</type><title>Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33</title><source>ScienceDirect Journals</source><creator>Routt, Ethan T., BA ; Levitt, Jacob O., MD</creator><creatorcontrib>Routt, Ethan T., BA ; Levitt, Jacob O., MD</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2013.10.054</identifier><identifier>PMID: 24438976</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Cutaneous ; Adult ; Brimonidine Tartrate ; Dermatology ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Erythema - chemically induced ; Erythema - physiopathology ; Female ; Follow-Up Studies ; Gels - therapeutic use ; Humans ; Pain - chemically induced ; Quinoxalines - adverse effects ; Quinoxalines - therapeutic use ; Recurrence ; Risk Assessment ; Rosacea - diagnosis ; Rosacea - drug therapy ; Sampling Studies ; Severity of Illness Index</subject><ispartof>Journal of the American Academy of Dermatology, 2014-02, Vol.70 (2), p.e37-e38</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2013 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603</citedby><cites>FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24438976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Routt, Ethan T., BA</creatorcontrib><creatorcontrib>Levitt, Jacob O., MD</creatorcontrib><title>Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Administration, Cutaneous</subject><subject>Adult</subject><subject>Brimonidine Tartrate</subject><subject>Dermatology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Erythema - chemically induced</subject><subject>Erythema - physiopathology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gels - therapeutic use</subject><subject>Humans</subject><subject>Pain - chemically induced</subject><subject>Quinoxalines - adverse effects</subject><subject>Quinoxalines - therapeutic use</subject><subject>Recurrence</subject><subject>Risk Assessment</subject><subject>Rosacea - diagnosis</subject><subject>Rosacea - drug therapy</subject><subject>Sampling Studies</subject><subject>Severity of Illness Index</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kd2L1TAQxYMo7nX1H_BB8uhL66RpmxREkMUvWBD8wMcwTadraptck3bl_vem3NUHH3waZjjnwPwOY08FlAJE-2IqJ8ShrEDIfCihqe-xg4BOFa3S6j47gOig6NqqumCPUpoAoKulesguqrqWulPtgX37RH3Y_MApntbvtCDHvPRb9M7f8EQ-4eqC52MMC0fu6Rdfw9FZnHkf3RK8G5wnvmJcI67Eb2jmUEr5mD0YcU705G5esq9v33y5el9cf3z34er1dWHrplkLPVZSktSDHBC0aqUla0WDSFKpxkprtaS6R5A1VnqoUIthFCjaVmrAFuQle37OPcbwc6O0msUlS_OMnsKWjKg76CATarO0OkttDClFGs0xf4DxZASYHaiZzA7U7ED3WwaaTc_u8rd-oeGv5Q_BLHh5FlD-8tZRNMk68pYGF8muZgju__mv_rHb2fmd7w86UZpCbiLzM8KkyoD5vFe6NyokCKGUlr8BFqSbJw</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Routt, Ethan T., BA</creator><creator>Levitt, Jacob O., MD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140201</creationdate><title>Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33</title><author>Routt, Ethan T., BA ; Levitt, Jacob O., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Cutaneous</topic><topic>Adult</topic><topic>Brimonidine Tartrate</topic><topic>Dermatology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Erythema - chemically induced</topic><topic>Erythema - physiopathology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gels - therapeutic use</topic><topic>Humans</topic><topic>Pain - chemically induced</topic><topic>Quinoxalines - adverse effects</topic><topic>Quinoxalines - therapeutic use</topic><topic>Recurrence</topic><topic>Risk Assessment</topic><topic>Rosacea - diagnosis</topic><topic>Rosacea - drug therapy</topic><topic>Sampling Studies</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Routt, Ethan T., BA</creatorcontrib><creatorcontrib>Levitt, Jacob O., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Routt, Ethan T., BA</au><au>Levitt, Jacob O., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>70</volume><issue>2</issue><spage>e37</spage><epage>e38</epage><pages>e37-e38</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24438976</pmid><doi>10.1016/j.jaad.2013.10.054</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2014-02, Vol.70 (2), p.e37-e38
issn 0190-9622
1097-6787
language eng
recordid cdi_proquest_miscellaneous_1490900136
source ScienceDirect Journals
subjects Administration, Cutaneous
Adult
Brimonidine Tartrate
Dermatology
Dose-Response Relationship, Drug
Drug Administration Schedule
Erythema - chemically induced
Erythema - physiopathology
Female
Follow-Up Studies
Gels - therapeutic use
Humans
Pain - chemically induced
Quinoxalines - adverse effects
Quinoxalines - therapeutic use
Recurrence
Risk Assessment
Rosacea - diagnosis
Rosacea - drug therapy
Sampling Studies
Severity of Illness Index
title Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A17%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rebound%20erythema%20and%20burning%20sensation%20from%20a%20new%20topical%20brimonidine%20tartrate%20gel%200.33&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Routt,%20Ethan%20T.,%20BA&rft.date=2014-02-01&rft.volume=70&rft.issue=2&rft.spage=e37&rft.epage=e38&rft.pages=e37-e38&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2013.10.054&rft_dat=%3Cproquest_cross%3E1490900136%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-8f233e38d3da08763cecc15aae3775c3cc83e4ba034a28d2a81df1a166380a603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490900136&rft_id=info:pmid/24438976&rfr_iscdi=true